First AD

Second AD

Breast Cancer

 Breast Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of breast cancer, including those that are triple negative, hormone receptor positive, and/or HER2 positive. This page features news articles, interviews in written and video format, and podcasts that focus on treatment advances and ongoing research in breast cancer.

Precision Medicine in Oncology®

The OncLive Precision Medicine in Oncology® condition center page is a comprehensive resource for clinical news and expert insights on precision-focused approaches in patients with cancer, with gene-targeted tyrosine kinase inhibitors and antibody-drug conjugates, checkpoint inhibitors, tumor-infiltrating lymphocyte therapy, and other tailored treatments. This page features news articles, interviews in written and video format, and podcasts that focus on updates and ongoing research with personalized therapies across solid and hematologic tumors.

Emerging Treatment Options for BRCA-Mutated Breast Cancer

OncLive News Network®

Emerging Options for BRCA-Mutated Breast Cancer Treatment

Implications for Germline BRCA Testing in Breast Cancer

Germline BRCA1/2: A New Subset of Breast Cancer

Chemotherapy in gBRCA1/2+ Metastatic Breast Cancer

Chemotherapy in Early-Stage gBRCA1/2+ Breast Cancer

Takeaways From the OlympiAD Trial

Olaparib: Predicting Response in Breast Cancer

Using Olaparib in gBRCA1/2+ Breast Cancer

Additional PARPs Under Investigation for Breast Cancer

PARP Inhibitors and Platinum Sensitivity or Resistance

Distinguishing Between PARP Inhibitors in Breast Cancer

PARP Inhibitors in Other Subtypes of Breast Cancer

Testing for Germline BRCA Mutations in the Future

Final Insight: PARPs and gBRCA in Breast Cancer